Dynamic appearance of antigenic epitopes effective for viral neutralization during membrane fusion initiated by interactions between HIV-1 envelope proteins and CD4/CXCR4.
HIV-1 entry into cells is mediated by interactions between the envelope (Env) gp120 and gp41 proteins with CD4 and chemokine receptors via an intermediate called the viral fusion complex (vFC). Here, mAbs were used to find the dynamic changes in expression of antigenic epitopes during vFC formation. A CD4-specific mAb (R275) and anti-vFC mAbs, designated F12-1, F13-6 and F18-4 that recognize the epitopes only appeared by the co-culture of env-transfected 293FT and CD4-transfected 293 cells, were developed by immunizing ganp-gene transgenic mice with an vFC-like structure formed by the same co-culture. The epitopes recognized by the mAbs appeared at different time points during vFC formation: F18-4 appeared first, followed by F13-6, and finally F12-1. The anti-vFC mAbs had little effect on vFC formation or virus neutralization; however, interestingly F12-1 and F18-4 increased exposure of the OKT4-epitope on the domain 3 in the extracellular region of CD4. R275, which recognizes the epitope closely associated with the OKT4-determinant on the domain 3, showed the marked inhibition of vFC formation and viral neutralization activity. The Ab binding to the epitopes appeared during viral membrane fusion might reinforce the appearance of the target epitopes for effective neutralization activity.
Department of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Teppei
T
Toda
Kazuhiko
K
Kuwahara
Naoyuki
N
Kondo
Zene
Z
Matsuda
Yosuke
Y
Maeda
Kazuhiko
K
Maeda
Nobuo
N
Sakaguchi
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000378:metabolism; D015704:CD4 Antigens / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D018984:Epitopes, T-Lymphocyte / Q000276:immunology* / Q000378:metabolism; D023061:Gene Order; D018390:Gene Targeting; D015483:HIV Antibodies / Q000276:immunology / Q000378:metabolism; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009500:Neutralization Tests; D011485:Protein Binding; D019718:Receptors, CXCR4 / Q000276:immunology / Q000378:metabolism*; D053586:Virus Internalization; D054299:env Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D018984:Epitopes, T-Lymphocyte; D015483:HIV Antibodies; D007141:Immunoglobulin Fc Fragments; D019718:Receptors, CXCR4; D054299:env Gene Products, Human Immunodeficiency Virus